These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3887670)
21. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection. Klintmalm G; Säwe J; Ringdén O; von Bahr C; Magnusson A Transplantation; 1985 Feb; 39(2):132-7. PubMed ID: 3881851 [TBL] [Abstract][Full Text] [Related]
22. Measurement of cyclosporine in plasma of cardiac allograft recipients by fluorescence polarization immunoassay. Rondanelli R; Regazzi MB; Gastaldi L; Legnazzi P; Abelli P Ther Drug Monit; 1990 Mar; 12(2):182-6. PubMed ID: 2180138 [TBL] [Abstract][Full Text] [Related]
23. Effects of temperature and endogenous factors in blood on concentrations of cyclosporin in plasma measured by high-performance liquid chromatography. Shibata N; Minouchi T; Hayashi Y; Shibata H; Ono T; Shimakawa H Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1877-80. PubMed ID: 2805168 [TBL] [Abstract][Full Text] [Related]
25. Determination of cyclosporin A in the serum of kidney transplant patients by rapid-flow fractionation and normal-phase high-performance liquid chromatography. Oka K; Hosoda K; Hirano T; Sakurai E; Kozaki M J Chromatogr; 1989 May; 490(1):145-54. PubMed ID: 2668308 [TBL] [Abstract][Full Text] [Related]
26. Relationship between erythrocyte-to-plasma distribution ratio of cyclosporin and lymphocyte proliferation in renal transplant patients. Shibata N; Hoshino N; Minouchi T; Yamaji A Eur J Clin Pharmacol; 1997; 51(6):455-9. PubMed ID: 9112059 [TBL] [Abstract][Full Text] [Related]
27. A model to account for the blood-to-plasma distribution of cyclosporin A in human blood. Shibata N; Minouchi T; Ono T; Shimakawa H J Pharmacobiodyn; 1990 Jan; 13(1):20-9. PubMed ID: 2341967 [TBL] [Abstract][Full Text] [Related]
28. Whole-blood cyclosporin G in renal transplant recipients determined by two immunoassays and liquid chromatography. McBride JH; Kim SS; Danovitch GM; Rodgerson DO; Reyes AF; Ota MK Clin Chem; 1993 Jul; 39(7):1415-9. PubMed ID: 8330399 [TBL] [Abstract][Full Text] [Related]
29. Cyclosporin drug monitoring: comparison of four immunoassays and HPLC. Kunzendorf U; Brockmöller J; Jochimsen F; Keller F; Roots I; Walz G; Offermann G Klin Wochenschr; 1989 Apr; 67(8):438-41. PubMed ID: 2657205 [TBL] [Abstract][Full Text] [Related]
30. Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment. Legg B; Rowland M Pharm Res; 1988 Feb; 5(2):80-5. PubMed ID: 3073383 [TBL] [Abstract][Full Text] [Related]
31. Improved liquid-chromatographic determination of cyclosporine, with concomitant detection of a cell-bound metabolite. Lensmeyer GL; Fields BL Clin Chem; 1985 Feb; 31(2):196-201. PubMed ID: 3967349 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of fluorescence polarization immunoassay for determination of cyclosporin in plasma. Hayashi Y; Shibata N; Minouchi T; Shibata H; Ono T; Shimakawa H Ther Drug Monit; 1989; 11(2):205-9. PubMed ID: 2655204 [TBL] [Abstract][Full Text] [Related]
33. Comparison of cyclosporin G (Nva2-cyclosporin) concentrations measured in whole blood by monoclonal fluorescence polarization immunoassay, monoclonal radioimmunoassay, and HPLC. Annesley TM; Coombs RC; Orsulak PJ Clin Chem; 1993 Jun; 39(6):1050-3. PubMed ID: 8504536 [TBL] [Abstract][Full Text] [Related]
34. Monitoring cyclosporin concentrations in marrow transplant recipients: comparison of two assay methods. Yee GC; Kennedy MS; Gmur DJ; Self SG; Deeg HJ Bone Marrow Transplant; 1987 Feb; 1(3):289-95. PubMed ID: 3332139 [TBL] [Abstract][Full Text] [Related]
35. Are anemic patients more sensitive to calcineurin inhibitors? Kobayashi T; Kuzuya T; Miwa Y; Liu D; Ma Y; Nagasaka T; Uchida K; Nakao A Transplant Proc; 2005 Mar; 37(2):1005-6. PubMed ID: 15848605 [TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Rosano TG; Freed BM; Cerilli J; Lempert N Transplantation; 1986 Sep; 42(3):262-7. PubMed ID: 2944258 [TBL] [Abstract][Full Text] [Related]
37. Use of a monoclonal antibody for the therapeutic monitoring of cyclosporine in plasma and whole blood. Copeland KR; Yatscoff RW Ther Drug Monit; 1988; 10(4):453-8. PubMed ID: 3201530 [TBL] [Abstract][Full Text] [Related]
38. Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit. Yee GC; McGuire TR; Gmur DJ; Lennon TP; Deeg HJ Transplantation; 1988 Sep; 46(3):399-402. PubMed ID: 3047931 [TBL] [Abstract][Full Text] [Related]
39. Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection. Veremis SA; Maddux MS; Tang IY; Millner SN; Prasad R; Pollak R; Mozes MF Transplant Proc; 1989 Feb; 21(1 Pt 2):1476-7. PubMed ID: 2652473 [No Abstract] [Full Text] [Related]
40. Cyclosporin A blood levels are not influenced by dietary alterations in lipids. Menon SP; Walker RJ; Duggin GG; Sullivan DR; Horvath JS; Tiller DJ Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):203-12. PubMed ID: 1876751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]